home.social

#obesity — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #obesity, aggregated by home.social.

  1. Cravings ‘like heroin withdrawal’: what happens when weight-loss drugs don’t work?
    By Nicola Davis Science correspondent

    GLP-1 medications have been a gamechanger in the fight against obesity. But for a minority of patients, their impact is negligible. Why?

    theguardian.com/science/2026/s

    #Weightlossdrugs #Obesity #Medicalresearch #Science #Society #UKnews #TheGuardian #NicolaDavisSciencecorrespondent

  2. The childhood obesity epidemic: an Indonesian teen’s story

    Childhood obesity rates are rising in Indonesia and other low- and middle-income countries, driven by increased consumption of processed foods and limited awareness of health risks. #News #Reuters #Newsfeed #obesity #epidemic #indonesia #weightloss #ozempic Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on X: Follow Reuters on…

    fllics.com/en/video/the-childh

  3. 'My body is your worst nightmare': Loving your body in GLP-1 era
    By Tegan Osborne

    Body acceptance in a era when social media is awash with before-and-after weight-loss content and aggressive marketing from companies selling GLP-1 drugs can be hard. But these experts have some tips.

    abc.net.au/news/2026-07-30/lov

    #Health #Obesity #Psychology #MentalHealth #DoctorsandMedicalProfessionals #TeganOsborne

  4. A team of researchers in Japan found a key biological component that may help explain why women tend to burn more calories from fat than men, which could help lead to new treatments for obesity and related diseases. japantimes.co.jp/news/2025/07/ #japan #sciencehealth #health #instituteofsciencetokyo #universityoftokyo #obesity

  5. #Wegovy®, #Zepbound®, and similar medications continue to gain attention for effectively treating #obesity, and now there is discussion—with research underway—about their potential for improving certain #surgical outcomes.

    The brand-name medications mentioned above belong to a class called GLP-1 (glucagon-like peptide-1) agonists. #GLP-1s mimic the actions of the GLP-1 hormone, which is secreted in the gut and sends an “I’m full” signal to the brain after you eat.

    GLP-1 medications aren’t new. @Ozempic® (generic name: #semaglutide) received approval from the U.S. Food and Drug Administration (FDA) to treat type 2 diabetes in 2017.

    After its weight-loss effects were studied, semaglutide (at a higher dose and sold under the name Wegovy) was approved by the FDA as an anti-obesity medication in 2021, and others have since followed.

    Most recently, the FDA approved Wegovy for patients with #cardiovascular #disease and obesity or overweight after a study showed that those taking the medication had a lower overall risk of major cardiac events, such as heart attack, stroke, or cardiovascular-related death.

    Now, some Yale Medicine surgeons believe, based on their ongoing research, that taking anti-obesity medications before and sometimes after total #joint #replacement and #bariatric #surgery can be beneficial.

    “These medications have been transformative, in terms of expanding the pool of people who can safely undergo joint replacement surgery,” says Daniel Wiznia, MD, a Yale Medicine orthopaedic surgeon and co-director of the Avascular Necrosis Program.

    “These anti-obesity medications are game-changers; they are changing the way people practice medicine.”

    Often, patients who need a total hip or knee replacement must delay surgery until they lose enough weight to meet specific body mass index ( #BMI ) standards.
    This is important in protecting the patient’s health.

    “Weight increases a patient’s risk of postoperative complications, including wound-healing problems, stroke, heart attack, blood clots, and infection,” he says.

    However, having patients take a GLP-1 medication before surgery, as well as improving their diet, has allowed more patients to reach a safe preoperative BMI, Dr. Wiznia says.

    yalemedicine.org/news/anti-obe